Novo Nordisk's gilded stock yields almost USD 59bn over 20 years

88 percent of Novo Nordisk’s net profits over the past three years have gone back to shareholders, reports CFO Karsten Munk Knudsen.

Karsten Munk Knudsen, chief financial officer at Novo Nordisk | Photo: Novo Nordisk / PR

As it turns out, shareholders in Novo Nordisk have made a good investment.

In addition to the fact that Novo Nordisk’s share price target has gone up by 3391.96 percent since the year 2000, the company also has a habit of letting it rain by rewarding its shareholders, reports Danish business daily Børsen.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs